COM:PANACEABIOTEC
Panacea Biotec
- Stock
Last Close
414.00
22/11 09:59
Market Cap
8.60B
Beta: -
Volume Today
119.87K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.44B - | 2.65B 8.67% | 3.08B 16.12% | 3.07B 0.40% | 3.21B 4.73% | 2.08B 35.26% | 1.15B 44.87% | 1.61B 40.46% | 1.93B 20.21% | 2.07B 7.23% | |
average payables | 2.14B - | 2.31B 7.82% | 1.98B 14.36% | 2.11B 6.82% | 1.20B 43.23% | 1.37B 14.05% | 2.34B 71.52% | 2.10B 10.19% | 2.41B 14.48% | 2.19B 9.26% | |
average receivables | 1.01B - | 1.42B 40.52% | 1.82B 27.82% | 2.42B 33.53% | 2.40B 0.93% | 3.01B 25.47% | 1.98B 34.31% | 866.46M 56.22% | 1.94B 124.01% | 1.41B 27.21% | |
book value per share | 83.71 - | 76.94 8.08% | 73.24 4.81% | 64.88 11.42% | 50.40 22.32% | 57.21 13.51% | 32.45 43.27% | -37.34 215.04% | 138.58 471.15% | 137.73 0.61% | |
capex per share | -9.14 - | -1.28 86.01% | -1.85 44.57% | -5.36 190.11% | -2.48 53.67% | -0.78 68.57% | -1.13 44.49% | -3.55 214.90% | -2.04 42.52% | -6.69 227.33% | |
capex to depreciation | -0.79 - | -0.12 85.21% | -0.15 32.56% | -0.49 214.19% | -0.26 46.41% | -0.09 66.57% | -0.16 80.17% | -0.47 201.65% | -0.29 39.34% | -1.05 265.34% | |
capex to operating cash flow | -0.93 - | -0.21 77.49% | -0.12 40.65% | -0.29 129.46% | -0.13 54.99% | -0.05 64.63% | 0.23 597.34% | -0.20 189.87% | 0.12 156.60% | 0.10 16.18% | |
capex to revenue | -0.11 - | -0.01 89.51% | -0.02 52.12% | -0.06 247.77% | -0.03 56.93% | -0.01 59.28% | -0.01 21.67% | -0.04 173.88% | -0.02 46.14% | -0.09 369.16% | |
cash per share | 4.05 - | 9.37 131.28% | 4.32 53.90% | 3.95 8.62% | 3.14 20.38% | 2.50 20.56% | 9.01 261.11% | 16.14 79.03% | 90.06 458.14% | 39.49 56.15% | |
days of inventory on hand | 374.91 - | 391.62 4.46% | 516.25 31.82% | 641.83 24.32% | 579.88 9.65% | 146.62 74.72% | 308.79 110.61% | 278.12 9.93% | 258.81 6.95% | 291.95 12.80% | |
days payables outstanding | 430.00 - | 264.01 38.60% | 314.36 19.07% | 492.27 56.59% | 6.02 98.78% | 485.64 7,963.82% | 415.76 14.39% | 354.48 14.74% | 316.05 10.84% | 256.16 18.95% | |
days sales outstanding | 93.68 - | 80.61 13.96% | 118.09 46.51% | 183.24 55.16% | 128.79 29.71% | 319.41 148.01% | 102.41 - | 118.98 16.18% | 53.70 54.87% | ||
debt to assets | 0.47 - | 0.53 13.47% | 0.57 8.20% | 0.53 7.67% | 0.59 10.99% | 0.47 19.69% | 0.53 13.58% | 0.70 30.23% | 0.02 97.24% | 0.02 16.98% | |
debt to equity | 1.76 - | 2.16 22.63% | 2.36 9.19% | 2.47 4.67% | 3.05 23.36% | 1.85 39.46% | 3.73 102.36% | -3.58 195.98% | 0.04 101.12% | 0.02 40.44% | |
dividend yield | |||||||||||
earnings yield | -0.19 - | -0.12 36.52% | -0.03 73.66% | -0.07 101.02% | -0.05 28.98% | 0.03 167.94% | -0.33 1,149.32% | -0.13 59.61% | 1.19 989.98% | -0.05 104.28% | |
enterprise value | 14.57B - | 18.31B 25.68% | 15.99B 12.63% | 19.46B 21.66% | 25.64B 31.78% | 18.30B 28.62% | 12.71B 30.58% | 18.63B 46.64% | 8.92B 52.15% | 6.45B 27.69% | |
enterprise value over ebitda | -5.79 - | 28.25 587.56% | 12.36 56.26% | 17.44 41.11% | 28.89 65.72% | -22.18 176.78% | 14.04 163.31% | 21.46 52.80% | -286.30 1,434.10% | -13.92 95.14% | |
ev to operating cash flow | 24.31 - | 49.17 102.27% | 17.64 64.13% | 16.97 3.78% | 21.73 28.03% | 17.45 19.67% | -41.70 338.94% | 17.45 141.85% | -8.22 147.11% | -1.52 81.48% | |
ev to sales | 2.83 - | 2.66 5.75% | 2.45 8.06% | 3.57 45.83% | 4.38 22.51% | 4.05 7.52% | 2.37 41.55% | 3.02 27.53% | 1.35 55.17% | 1.40 3.63% | |
free cash flow per share | 0.64 - | 4.80 646.19% | 12.96 169.97% | 13.36 3.09% | 16.78 25.65% | 16.34 2.64% | -6.10 137.35% | 13.88 327.39% | -19.75 242.29% | -75.82 283.97% | |
free cash flow yield | 0.01 - | 0.03 398.70% | 0.14 314.05% | 0.08 41.20% | 0.06 24.30% | 0.08 33.24% | -0.07 178.70% | 0.08 218.01% | -0.13 271.76% | -0.70 424.71% | |
graham net net | -194.48 - | -184.40 5.19% | -174.23 5.51% | -176.57 1.34% | -156.80 11.20% | -110.24 29.69% | -173.96 57.79% | -178.71 2.73% | -19.19 89.26% | -6.10 68.22% | |
graham number | 185.69 - | 173.51 6.56% | 70.15 59.57% | 123.95 76.69% | 118.61 4.30% | 89.04 24.93% | 149.65 68.08% | 141.61 5.38% | 740.74 423.10% | 130.67 82.36% | |
income quality | -0.54 - | -0.35 35.27% | -4.79 1,270.59% | -2.02 57.80% | -1.78 11.73% | 2.27 227.14% | 0.17 92.43% | -0.74 528.46% | -0.07 89.83% | -33.08 44,102.19% | |
intangibles to total assets | 0.03 - | 0.02 18.87% | 0.02 23.63% | 0.02 21.72% | 0.02 24.16% | 0.01 49.70% | 0.01 2.30% | 0.01 9.71% | 0.01 39.94% | 0.02 163.13% | |
interest coverage | -1.03 - | -0.16 84.74% | -0.53 236.35% | 0.40 175.34% | -1.23 411.05% | 0.27 121.71% | 0.22 17.58% | -0.26 217.89% | -19.24 7,296.77% | ||
interest debt per share | 147.56 - | 182.17 23.45% | 192.63 5.75% | 177.89 7.66% | 169.32 4.81% | 119.42 29.47% | 149.43 25.13% | 163.95 9.71% | 34.94 78.69% | 4.03 88.48% | |
inventory turnover | 0.97 - | 0.93 4.27% | 0.71 24.14% | 0.57 19.57% | 0.63 10.68% | 2.49 295.50% | 1.18 52.52% | 1.31 11.03% | 1.41 7.46% | 1.25 11.35% | |
invested capital | 1.76 - | 2.16 22.63% | 2.36 9.19% | 2.47 4.67% | 3.05 23.36% | 1.85 39.46% | 3.73 102.36% | -3.58 195.98% | 0.04 101.12% | 0.02 40.44% | |
market cap | 5.78B - | 8.64B 49.63% | 5.64B 34.80% | 9.88B 75.33% | 16.40B 66.00% | 11.98B 26.93% | 5.69B 52.55% | 10.96B 92.69% | 9.08B 17.16% | 6.64B 26.82% | |
net current asset value | -10.44B - | -9.30B 10.93% | -8.56B 7.95% | -8.54B 0.25% | -7.41B 13.18% | -5.20B 29.84% | -5.11B 1.72% | -9.00B 75.94% | 1.04B 111.55% | 1.37B 32.16% | |
net debt to ebitda | -3.50 - | 14.91 526.50% | 8.00 46.34% | 8.58 7.25% | 10.42 21.35% | -7.66 173.55% | 7.76 201.29% | 8.84 13.93% | 5.20 41.16% | 0.42 91.85% | |
net income per share | -18.31 - | -17.39 5.01% | -2.99 82.83% | -10.52 252.43% | -12.41 17.90% | 6.16 149.64% | -30.67 597.95% | -23.87 22.17% | 175.98 837.25% | -5.51 103.13% | |
operating cash flow per share | 9.78 - | 6.08 37.87% | 14.81 143.59% | 18.72 26.43% | 19.27 2.93% | 17.12 11.14% | -4.97 129.05% | 17.43 450.39% | -17.70 201.57% | -69.13 290.51% | |
payables turnover | 0.85 - | 1.38 62.87% | 1.16 16.02% | 0.74 36.14% | 60.61 8,073.85% | 0.75 98.76% | 0.88 16.81% | 1.03 17.29% | 1.15 12.16% | 1.42 23.38% | |
receivables turnover | 3.90 - | 4.53 16.22% | 3.09 31.74% | 1.99 35.55% | 2.83 42.28% | 1.14 59.68% | 3.56 - | 3.07 13.93% | 6.80 121.56% | ||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.06 - | -0.06 4.85% | -0.01 82.21% | -0.04 252.21% | -0.05 37.22% | 0.03 157.32% | -0.14 592.51% | -0.13 8.11% | 0.61 585.03% | -0.03 104.45% | |
revenue per share | 84.14 - | 112.19 33.34% | 106.62 4.96% | 88.95 16.58% | 95.68 7.57% | 73.85 22.81% | 87.70 18.76% | 100.84 14.98% | 107.63 6.73% | 75.09 30.23% | |
roe | -0.22 - | -0.23 3.34% | -0.04 81.96% | -0.16 297.86% | -0.25 51.78% | 0.11 143.73% | -0.95 977.72% | 0.64 167.65% | 1.27 98.64% | -0.04 103.15% | |
roic | -0.08 - | -0.07 13.50% | -0.01 79.89% | -0.04 216.81% | 0.04 180.17% | -0.09 351.76% | 0.05 161.10% | 0.07 29.37% | -0.04 156.38% | 0.26 761.53% | |
sales general and administrative to revenue | 0.04 - | 0.03 14.12% | 0.04 13.08% | 0.05 35.11% | 0.04 28.85% | 0.04 17.92% | 0.04 5.61% | ||||
shareholders equity per share | 83.71 - | 76.94 8.08% | 73.24 4.81% | 64.88 11.42% | 50.40 22.32% | 57.21 13.51% | 32.45 43.27% | -37.34 215.04% | 138.58 471.15% | 137.73 0.61% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 4.68B - | 4.35B 7.22% | 4.20B 3.30% | 3.61B 14.00% | 2.67B 26.07% | 3.31B 23.79% | 1.79B 45.78% | -2.47B 237.64% | 8.32B 436.95% | 8.14B 2.14% | |
tangible book value per share | 84.60 - | 77.50 8.39% | 73.42 5.27% | 64.88 11.63% | 43.63 32.75% | 54.01 23.79% | 29.29 45.78% | -40.31 237.64% | 135.83 436.95% | 132.92 2.14% | |
working capital | -4.56B - | -1.80B 60.42% | 737.90M 140.92% | 111.40M 84.90% | -1.31B 1,273.06% | -4.30B 229.34% | 2.28B 152.99% | 853.09M 62.59% | 2.38B 178.73% | 2.36B 0.55% |
All numbers in (except ratios and percentages)